ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for DNLI

Stock NameDenali Therapeutics Inc
TickerDNLI(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS24823R1059
LEI549300ZTQ2HO18L3Q830

Show aggregate DNLI holdings

News associated with DNLI

Financial Survey: Denali Therapeutics (NASDAQ:DNLI) & Celcuity (NASDAQ:CELC)
Denali Therapeutics (NASDAQ:DNLI – Get Free Report) and Celcuity (NASDAQ:CELC – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations. Analyst Ratings This is a summary of current ratings […] - 2025-09-17 02:12:56
Denali Therapeutics (NASDAQ:DNLI) Receives “Overweight” Rating from Cantor Fitzgerald
Cantor Fitzgerald restated their overweight rating on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a research note released on Monday morning,Benzinga reports. Other research analysts have also recently issued reports about the company. TD Cowen raised Denali Therapeutics to a “strong-buy” rating in a report on Monday, July 28th. Morgan Stanley dropped their […] - 2025-09-09 02:50:44
Denali Therapeutics (NASDAQ:DNLI) Upgraded at TD Cowen
Denali Therapeutics (NASDAQ:DNLI – Get Free Report) was upgraded by TD Cowen to a “strong-buy” rating in a research note issued to investors on Monday,Zacks.com reports. DNLI has been the subject of a number of other reports. Cantor Fitzgerald raised shares of Denali Therapeutics from a “neutral” rating to an “overweight” rating in a research […] - 2025-07-30 02:20:44
Denali Therapeutics Inc. (NASDAQ:DNLI) Given Average Rating of “Buy” by Brokerages
Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) has received an average rating of “Buy” from the seventeen analysts that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company. […] - 2025-07-29 02:30:59
New York State Common Retirement Fund Has $955,000 Stake in Denali Therapeutics Inc. (NASDAQ:DNLI)
New York State Common Retirement Fund decreased its position in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 51.5% in the first quarter, HoldingsChannel reports. The firm owned 70,240 shares of the company’s stock after selling 74,484 shares during the period. New York State Common Retirement Fund’s holdings in Denali Therapeutics were worth $955,000 at […] - 2025-07-25 04:56:54
DekaBank Deutsche Girozentrale Raises Position in Denali Therapeutics Inc. (NASDAQ:DNLI)
DekaBank Deutsche Girozentrale raised its holdings in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 7.4% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 64,210 shares of the company’s stock after acquiring an additional 4,410 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Denali Therapeutics were worth $935,000 as of its most […] - 2025-07-14 06:44:51
Denali Therapeutics Inc. (NASDAQ:DNLI) CEO Ryan J. Watts Sells 495,282 Shares
Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) CEO Ryan J. Watts sold 495,282 shares of Denali Therapeutics stock in a transaction on Wednesday, July 9th. The shares were sold at an average price of $15.00, for a total value of $7,429,230.00. Following the completion of the transaction, the chief executive officer owned 253,071 shares […] - 2025-07-14 05:10:49
LABU's Holdings Imply 58% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-10 07:59:01
Denali Therapeutics Inc. (NASDAQ:DNLI) Receives $33.71 Average PT from Brokerages
Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) has earned an average recommendation of “Buy” from the seventeen research firms that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating […] - 2025-06-12 02:28:50
Analysts Anticipate VB To Hit $270
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-09 08:43:39
Two Sigma Advisers LP Acquires Shares of 15,100 Denali Therapeutics Inc. (NASDAQ:DNLI)
Two Sigma Advisers LP acquired a new stake in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 15,100 shares of the company’s stock, valued at approximately $308,000. Other hedge funds also recently bought […] - 2025-06-06 05:12:49
Squarepoint Ops LLC Purchases 14,896 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Squarepoint Ops LLC grew its position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 44.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 48,619 shares of the company’s stock after buying an additional 14,896 shares during the quarter. Squarepoint […] - 2025-06-01 05:31:11
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 3,411 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 4.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 85,075 shares of the company’s stock after purchasing an additional 3,411 shares during […] - 2025-05-23 06:26:52
Janus Henderson Group PLC Purchases 7,900 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Janus Henderson Group PLC grew its holdings in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 15.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 60,028 shares of the company’s stock after purchasing an additional 7,900 shares during the quarter. Janus Henderson Group PLC’s […] - 2025-05-23 05:26:51
Bank of America Cuts Denali Therapeutics (NASDAQ:DNLI) Price Target to $27.00
Denali Therapeutics (NASDAQ:DNLI – Get Free Report) had its price objective reduced by research analysts at Bank of America from $28.00 to $27.00 in a report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Bank of America‘s price objective suggests a potential upside of 88.94% from the stock’s current […] - 2025-05-21 02:56:58
Deutsche Bank AG Buys 37,907 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Deutsche Bank AG boosted its position in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 15.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 277,853 shares of the company’s stock after purchasing an additional 37,907 shares during the period. Deutsche Bank AG’s holdings in Denali Therapeutics were worth $5,663,000 as of its most […] - 2025-05-19 05:06:53
Denali Therapeutics Inc. (NASDAQ:DNLI) Shares Bought by Northern Trust Corp
Northern Trust Corp grew its stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 10.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,201,518 shares of the company’s stock after acquiring an additional 115,876 shares during the […] - 2025-05-13 05:28:54
Denali Therapeutics (NASDAQ:DNLI) Trading Down 10.1% Following Weak Earnings
Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report)’s stock price was down 10.1% on Tuesday following a dissappointing earnings announcement. The stock traded as low as $14.41 and last traded at $14.38. Approximately 525,609 shares changed hands during trading, a decline of 52% from the average daily volume of 1,084,610 shares. The stock had previously […] - 2025-05-08 03:08:47
Dimensional Fund Advisors LP Has $37.81 Million Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI)
Dimensional Fund Advisors LP lifted its holdings in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 19.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,855,036 shares of the company’s stock after purchasing an additional 295,594 shares during the period. […] - 2025-05-05 05:20:52
Sterling Capital Management LLC Has $36,000 Stake in Denali Therapeutics Inc. (NASDAQ:DNLI)
Sterling Capital Management LLC raised its stake in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 589.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,773 shares of the company’s stock after purchasing an additional 1,516 shares during the quarter. Sterling […] - 2025-04-25 05:34:52
Franklin Resources Inc. Decreases Position in Denali Therapeutics Inc. (NASDAQ:DNLI)
Franklin Resources Inc. reduced its position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 6.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 74,862 shares of the company’s stock after selling 5,179 shares during the period. […] - 2025-04-15 04:56:57
Pictet Asset Management Holding SA Grows Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI)
Pictet Asset Management Holding SA raised its stake in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 17.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 19,356 shares of the company’s stock after buying an additional 2,806 shares during the […] - 2025-04-10 05:37:07
Sei Investments Co. Lowers Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI)
Sei Investments Co. decreased its stake in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 8.5% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 24,047 shares of the company’s stock after selling 2,229 shares during the quarter. Sei Investments Co.’s holdings in Denali Therapeutics were worth $490,000 at the end of the […] - 2025-04-10 04:18:49
1,065,608 Shares in Denali Therapeutics Inc. (NASDAQ:DNLI) Purchased by Norges Bank
Norges Bank bought a new position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm bought 1,065,608 shares of the company’s stock, valued at approximately $21,717,000. Several other hedge funds also recently made changes to their […] - 2025-04-07 04:51:10
Schroder Investment Management Group Has $5.02 Million Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI)
Schroder Investment Management Group increased its position in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 94.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 247,800 shares of the company’s stock after purchasing an additional 120,494 shares during the […] - 2025-04-06 05:29:07
Corebridge Financial Inc. Sells 4,665 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Corebridge Financial Inc. lowered its position in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 7.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 61,800 shares of the company’s stock after selling 4,665 shares during the quarter. […] - 2025-04-04 05:09:15
American Century Companies Inc. Buys 29,155 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
American Century Companies Inc. raised its holdings in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 6.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 480,529 shares of the company’s stock after buying an additional 29,155 shares during the period. American Century Companies Inc.’s […] - 2025-04-03 04:32:51
Teacher Retirement System of Texas Purchases 5,987 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Teacher Retirement System of Texas grew its holdings in shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 18.6% in the 4th quarter, Holdings Channel reports. The fund owned 38,178 shares of the company’s stock after buying an additional 5,987 shares during the period. Teacher Retirement System of Texas’ holdings in Denali Therapeutics were […] - 2025-03-31 05:00:58
Cibc World Markets Corp Purchases Shares of 11,633 Denali Therapeutics Inc. (NASDAQ:DNLI)
Cibc World Markets Corp acquired a new position in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 11,633 shares of the company’s stock, valued at approximately $237,000. Other large investors have also modified their holdings […] - 2025-03-26 06:09:01
Denali Therapeutics Inc. (NASDAQ:DNLI) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eighteen research firms that are covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation, fifteen have assigned a buy recommendation and one has assigned a strong buy […] - 2025-03-26 04:26:42

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc DNLI holdings

DateNumber of DNLI Shares HeldBase Market Value of DNLI SharesLocal Market Value of DNLI SharesChange in DNLI Shares HeldChange in DNLI Base ValueCurrent Price per DNLI Share HeldPrevious Price per DNLI Share Held
2026-01-15 (Thursday)31,822DNLI holding increased by 4888USD 597,617DNLI holding increased by 105533USD 597,6174,888USD 105,533 USD 18.78 USD 18.27
2026-01-14 (Wednesday)26,934DNLI holding increased by 94USD 492,084DNLI holding increased by 6012USD 492,08494USD 6,012 USD 18.27 USD 18.11
2026-01-13 (Tuesday)26,840USD 486,072DNLI holding increased by 4294USD 486,0720USD 4,294 USD 18.11 USD 17.95
2026-01-12 (Monday)26,840USD 481,778DNLI holding increased by 23351USD 481,7780USD 23,351 USD 17.95 USD 17.08
2026-01-09 (Friday)26,840USD 458,427DNLI holding increased by 268USD 458,4270USD 268 USD 17.08 USD 17.07
2026-01-08 (Thursday)26,840DNLI holding increased by 94USD 458,159DNLI holding increased by 4814USD 458,15994USD 4,814 USD 17.07 USD 16.95
2026-01-07 (Wednesday)26,746USD 453,345DNLI holding decreased by -6954USD 453,3450USD -6,954 USD 16.95 USD 17.21
2026-01-06 (Tuesday)26,746USD 460,299DNLI holding increased by 31828USD 460,2990USD 31,828 USD 17.21 USD 16.02
2026-01-05 (Monday)26,746USD 428,471DNLI holding decreased by -6686USD 428,4710USD -6,686 USD 16.02 USD 16.27
2026-01-02 (Friday)26,746USD 435,157DNLI holding decreased by -6419USD 435,1570USD -6,419 USD 16.27 USD 16.51
2025-12-31 (Wednesday)26,746USD 441,576DNLI holding increased by 2674USD 441,5760USD 2,674 USD 16.51 USD 16.41
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of DNLI by Blackrock for IE00B3VWM098

Show aggregate share trades of DNLI

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-01-15BUY4,88818.98017.880 17.990USD 87,935 17.57
2026-01-14BUY9418.48017.940 17.994USD 1,691 17.57
2026-01-08BUY9417.57016.640 16.733USD 1,573 17.57
2025-12-23SELL-9417.61516.720 16.809USD -1,580 17.61 Profit of 75 on sale
2025-12-03SELL-47019.15817.900 18.026USD -8,472 17.57 Loss of -213 on sale
2025-12-02BUY18818.48017.650 17.733USD 3,334 17.57
2025-11-25SELL-28219.63018.875 18.950USD -5,344 17.53 Loss of -400 on sale
2025-11-24SELL-28218.99518.030 18.127USD -5,112 17.53 Loss of -169 on sale
2025-11-17SELL-1,03417.83017.250 17.308USD -17,896 17.53 Profit of 230 on sale
2025-11-12SELL-9418.70017.170 17.323USD -1,628 17.53 Profit of 20 on sale
2025-11-06SELL-9415.10014.300 14.380USD -1,352 17.57 Profit of 300 on sale
2025-11-05SELL-94014.99014.560 14.603USD -13,727 17.59 Profit of 2,804 on sale
2025-11-04SELL-18815.29014.830 14.876USD -2,797 17.60 Profit of 512 on sale
2025-11-03SELL-18816.33015.140 15.259USD -2,869 17.61 Profit of 442 on sale
2025-10-28BUY28216.92017.020 17.010USD 4,797 17.64
2025-10-24SELL-9415.96016.410 16.365USD -1,538 17.65 Profit of 121 on sale
2025-10-15BUY56416.31016.430 16.418USD 9,260 17.70
2025-10-02BUY9415.20015.680 15.632USD 1,469 17.73
2025-09-30BUY18814.52014.580 14.574USD 2,740 17.76
2025-08-21SELL-9415.23015.340 15.329USD -1,441 17.87 Profit of 239 on sale
2025-07-31BUY28213.83014.129 14.099USD 3,976 17.92
2025-06-30SELL-18813.99014.550 14.494USD -2,725 18.38 Profit of 731 on sale
2025-06-25SELL-9414.45014.788 14.754USD -1,387 18.47 Profit of 349 on sale
2025-06-20SELL-18813.89014.130 14.106USD -2,652 18.56 Profit of 838 on sale
2025-05-23BUY9413.42013.640 13.618USD 1,280 19.30
2025-05-19SELL-9413.91014.210 14.180USD -1,333 19.49 Profit of 499 on sale
2025-05-15SELL-28214.16014.205 14.200USD -4,005 19.59 Profit of 1,519 on sale
2025-05-12SELL-9414.80015.560 15.484USD -1,455 19.73 Profit of 399 on sale
2025-05-09SELL-9414.37015.310 15.216USD -1,430 19.78 Profit of 429 on sale
2025-04-30SELL-9416.65016.845 16.825USD -1,582 20.07 Profit of 305 on sale
2025-04-24SELL-18815.49015.670 15.652USD -2,943 20.24 Profit of 863 on sale
2025-04-17SELL-9412.74012.870 12.857USD -1,209 20.59 Profit of 727 on sale
2025-04-15SELL-28213.17013.630 13.584USD -3,831 20.76 Profit of 2,024 on sale
2025-04-14SELL-28213.27013.330 13.324USD -3,757 20.84 Profit of 2,120 on sale
2025-04-09SELL-37612.86013.360 13.310USD -5,005 21.12 Profit of 2,937 on sale
2025-04-07SELL-65811.60011.870 11.843USD -7,793 21.34 Profit of 6,251 on sale
2025-04-04SELL-94011.78012.630 12.545USD -11,792 21.46 Profit of 8,377 on sale
2025-03-31BUY9413.59514.390 14.311USD 1,345 21.76
2025-03-19SELL-18814.82015.025 15.004USD -2,821 22.55 Profit of 1,418 on sale
2025-03-14SELL-56415.15015.700 15.645USD -8,824 22.87 Profit of 4,073 on sale
2025-03-13SELL-18814.89016.160 16.033USD -3,014 22.98 Profit of 1,306 on sale
2025-03-12SELL-3,19615.95016.280 16.247USD -51,925 23.08 Profit of 21,846 on sale
2025-03-07SELL-18816.69016.970 16.942USD -3,185 23.42 Profit of 1,219 on sale
2025-03-06SELL-28216.27016.350 16.342USD -4,608 23.53 Profit of 2,028 on sale
2025-03-03SELL-9415.20016.785 16.626USD -1,563 23.91 Profit of 684 on sale
2025-02-28SELL-63,32316.56019.000 18.756USD -1,187,686 24.03 Profit of 333,851 on sale
2025-02-26SELL-26118.89019.660 19.583USD -5,111 24.21 Profit of 1,207 on sale
2025-02-25SELL-78319.20020.830 20.667USD -16,182 24.29 Profit of 2,840 on sale
2025-02-18BUY1,30521.79022.270 22.222USD 29,000 24.57
2025-02-13BUY26121.31021.540 21.517USD 5,616 24.76
2025-02-12BUY26120.82021.030 21.009USD 5,483 24.84
2025-02-11BUY78320.58021.510 21.417USD 16,770 24.93
2025-02-06BUY2,34022.53023.785 23.659USD 55,363 25.13
2025-01-27BUY26023.19023.200 23.199USD 6,032 25.55
2024-12-30BUY1,30020.24020.510 20.483USD 26,628 26.03
2024-12-06BUY1,04024.89025.000 24.989USD 25,989 26.15
2024-12-05BUY26023.32023.605 23.576USD 6,130 26.25
2024-12-04BUY1,30023.70024.360 24.294USD 31,582 26.34
2024-11-29BUY1,30025.00025.420 25.378USD 32,991 26.52
2024-11-27BUY1,04025.16025.420 25.394USD 26,410 26.64
2024-11-26BUY26024.68024.945 24.918USD 6,479 26.73
2024-11-21BUY1,30024.22024.790 24.733USD 32,153 27.09
2024-11-20BUY78024.42024.830 24.789USD 19,335 27.23
2024-11-18BUY3,11024.18025.350 25.233USD 78,475 27.61
2024-11-12BUY2,07229.89031.470 31.312USD 64,878 27.45
2024-11-08BUY1,29531.35031.460 31.449USD 40,726 27.18
2024-11-07BUY3,88529.60031.405 31.225USD 121,307 26.99
2024-11-06BUY51829.55029.600 29.595USD 15,330 26.78
2024-10-31BUY25925.96026.740 26.662USD 6,905 26.68
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of DNLI

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19378,1591,201906,79941.7%
2025-09-18267,7057,938845,21031.7%
2025-09-17409,8617001,166,91035.1%
2025-09-16391,4953001,419,69727.6%
2025-09-15260,6650671,93738.8%
2025-09-12206,5700814,13725.4%
2025-09-11275,762207657,64941.9%
2025-09-10329,3340769,46042.8%
2025-09-09309,1050685,69045.1%
2025-09-08379,188581,067,13235.5%
2025-09-05349,05902,670,12813.1%
2025-09-04280,93711,807555,93150.5%
2025-09-03417,11301,357,89530.7%
2025-09-02422,8855,2053,059,39813.8%
2025-08-29549,1503991,42655.4%
2025-08-28543,2797501,001,43854.2%
2025-08-27366,4270654,68656.0%
2025-08-26644,04801,095,69658.8%
2025-08-25291,7840587,61749.7%
2025-08-22312,5542001,397,37122.4%
2025-08-21399,0820875,60745.6%
2025-08-20326,1840625,31752.2%
2025-08-19264,8630410,14164.6%
2025-08-18309,6690516,16360.0%
2025-08-15209,5600463,25645.2%
2025-08-14332,064232818,15240.6%
2025-08-13524,4520992,83852.8%
2025-08-12325,3181,582713,95745.6%
2025-08-11295,5850597,42849.5%
2025-08-08698,45101,028,93567.9%
2025-08-07587,3230987,05159.5%
2025-08-06756,41301,219,50362.0%
2025-08-05416,20026,5981,111,99037.4%
2025-08-04474,241500928,76651.1%
2025-08-01365,6410787,31546.4%
2025-07-31376,07266896,40342.0%
2025-07-30509,9618956,41753.3%
2025-07-29282,88812622,53745.4%
2025-07-28292,3510614,15247.6%
2025-07-25234,2670458,04151.1%
2025-07-24289,89984723,17640.1%
2025-07-23345,904711676,12951.2%
2025-07-22228,07998411,31555.5%
2025-07-21237,8200416,45357.1%
2025-07-18226,5110419,95953.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy